These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2838975)

  • 1. Hepatocellular carcinoma in hepatitis B surface antigen carriers in eight institutions.
    Lohiya GS; Pirkle H; Nguyen H; Lohiya S; Vuu T
    West J Med; 1988 Apr; 148(4):426-9. PubMed ID: 2838975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HBsAg carrier state and primary hepatocellular carcinoma--a ten-year prospective study].
    Lu JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 1988 Sep; 22(5):259-62. PubMed ID: 2853039
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis BeAg in chronic asymptomatic hepatitis B surface antigen carriers and in primary hepatocellular carcinoma patients.
    Tswana SA
    Cent Afr J Med; 1986 May; 32(5):113-6. PubMed ID: 3028639
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatocellular carcinoma and type B hepatitis.
    Hadziyannis SJ
    Clin Gastroenterol; 1980 Jan; 9(1):117-34. PubMed ID: 6249525
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver disease and hepatitis B infection in a large New Zealand family.
    Milne A; Moyes CD; Pearce NE
    N Z Med J; 1989 Jun; 102(870):318-20. PubMed ID: 2544833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Matched prospective study on chronic HBsAg carriers and primary hepatocellular cancer].
    Lu JH
    Zhonghua Zhong Liu Za Zhi; 1983 Nov; 5(6):406-8. PubMed ID: 6327215
    [No Abstract]   [Full Text] [Related]  

  • 8. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
    Khin LW; Teo CJ; Guan R
    Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma.
    Chen WN; Oon CJ
    Biochem Biophys Res Commun; 1999 Sep; 262(3):757-61. PubMed ID: 10471398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
    Jee SH; Ohrr H; Sull JW; Samet JM
    J Natl Cancer Inst; 2004 Dec; 96(24):1851-6. PubMed ID: 15601641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California.
    Yu MC; Yuan JM; Ross RK; Govindarajan S
    Hepatology; 1997 Jan; 25(1):226-8. PubMed ID: 8985295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
    Okuda H; Obata H; Motoike Y; Hisamitsu T
    Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of the correlation between primary hepatocellular carcinoma and hepatitis B].
    Lu CQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1988 Feb; 9(1):5-7. PubMed ID: 2838172
    [No Abstract]   [Full Text] [Related]  

  • 15. [What is the disease course in carriers of HBsAg?].
    González A; Guardia J
    Med Clin (Barc); 1989 Dec; 93(19):737-40. PubMed ID: 2560101
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolving concepts of the clinical and serologic consequences of hepatitis B virus infection.
    Seeff LB; Koff RS
    Semin Liver Dis; 1986 Feb; 6(1):11-22. PubMed ID: 3012782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis B viral markers in hepatitis B endemic areas of China.
    Luo S; Ye FS; Mo ZC; Su YX; He JS; Zhou CQ; Tong MJ; Henderson BE; Yu MC
    Chin Med J (Engl); 1988 Sep; 101(9):654-8. PubMed ID: 2466618
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocellular carcinoma in young, mentally retarded HBsAg carriers without cirrhosis.
    Lohiya G; Pirkle H; Hoefs J; Lohiya S; Ngo VT
    Hepatology; 1985; 5(5):824-6. PubMed ID: 2993146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
    Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
    Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of hepatocellular carcinoma complicating hepatitis B infection in a nine-year-old boy.
    Trounce JQ; Flower AJ; Shannon RS; Tanner MS
    Q J Med; 1985 Nov; 57(223):791-4. PubMed ID: 3001813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.